img

Global Feline Vaccines Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Feline Vaccines Market Insights, Forecast to 2034

Feline vaccinations stimulate your kitten or cat's immune system in order to create protection from specific infectious diseases. This can cause mild symptoms to occur ranging from soreness at the injection site to fever and allergic reactions.
Global Feline Vaccines market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Feline Vaccines industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Feline Vaccines key manufacturers include Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac and Kyoto Biken Laboratories, etc. Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer) are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Feline Vaccines were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Feline Vaccines market and estimated to attract more attentions from industry insiders and investors.
Feline Vaccines can be divided into F3 (FVRCP) Vaccination, Feline Leukaemia Vaccination, Rabies Vaccination and Heartworm Vaccination, etc. F3 (FVRCP) Vaccination is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Feline Vaccines is widely used in various fields, such as Prevention of Feline Panleukopaenia, Prevention of Feline Rhinotracheitis, Prevention of Feline Calicivirus and Others, etc. Prevention of Feline Panleukopaenia provides greatest supports to the Feline Vaccines industry development. In 2022, global % sales of Feline Vaccines went into Prevention of Feline Panleukopaenia filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Feline Vaccines market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Feline Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck & Co
Boehringer Ingelheim International
Zoetis (Pfizer)
Elanco Animal Health
Virbac
Kyoto Biken Laboratories
Segment by Type
F3 (FVRCP) Vaccination
Feline Leukaemia Vaccination
Rabies Vaccination
Heartworm Vaccination
Others

Segment by Application


Prevention of Feline Panleukopaenia
Prevention of Feline Rhinotracheitis
Prevention of Feline Calicivirus
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Feline Vaccines plant distribution, commercial date of Feline Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Feline Vaccines introduction, etc. Feline Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Feline Vaccines
Chapter 15Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Study Coverage
1.1 Feline Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Feline Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 F3 (FVRCP) Vaccination
1.2.3 Feline Leukaemia Vaccination
1.2.4 Rabies Vaccination
1.2.5 Heartworm Vaccination
1.2.6 Others
1.3 Market by Application
1.3.1 Global Feline Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Prevention of Feline Panleukopaenia
1.3.3 Prevention of Feline Rhinotracheitis
1.3.4 Prevention of Feline Calicivirus
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Feline Vaccines Sales Estimates and Forecasts 2018-2033
2.2 Global Feline Vaccines Revenue by Region
2.2.1 Global Feline Vaccines Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global Feline Vaccines Revenue by Region (2018-2023)
2.2.3 Global Feline Vaccines Revenue by Region (2024-2033)
2.2.4 Global Feline Vaccines Revenue Market Share by Region (2018-2033)
2.3 Global Feline Vaccines Sales Estimates and Forecasts 2018-2033
2.4 Global Feline Vaccines Sales by Region
2.4.1 Global Feline Vaccines Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global Feline Vaccines Sales by Region (2018-2023)
2.4.3 Global Feline Vaccines Sales by Region (2024-2033)
2.4.4 Global Feline Vaccines Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Feline Vaccines Sales by Manufacturers
3.1.1 Global Feline Vaccines Sales by Manufacturers (2018-2023)
3.1.2 Global Feline Vaccines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Feline Vaccines in 2022
3.2 Global Feline Vaccines Revenue by Manufacturers
3.2.1 Global Feline Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Feline Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Feline Vaccines Revenue in 2022
3.3 Global Key Players of Feline Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Feline Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Feline Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Feline Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Feline Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Feline Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Feline Vaccines Sales by Type
4.1.1 Global Feline Vaccines Historical Sales by Type (2018-2023)
4.1.2 Global Feline Vaccines Forecasted Sales by Type (2024-2033)
4.1.3 Global Feline Vaccines Sales Market Share by Type (2018-2033)
4.2 Global Feline Vaccines Revenue by Type
4.2.1 Global Feline Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Feline Vaccines Forecasted Revenue by Type (2024-2033)
4.2.3 Global Feline Vaccines Revenue Market Share by Type (2018-2033)
4.3 Global Feline Vaccines Price by Type
4.3.1 Global Feline Vaccines Price by Type (2018-2023)
4.3.2 Global Feline Vaccines Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global Feline Vaccines Sales by Application
5.1.1 Global Feline Vaccines Historical Sales by Application (2018-2023)
5.1.2 Global Feline Vaccines Forecasted Sales by Application (2024-2033)
5.1.3 Global Feline Vaccines Sales Market Share by Application (2018-2033)
5.2 Global Feline Vaccines Revenue by Application
5.2.1 Global Feline Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Feline Vaccines Forecasted Revenue by Application (2024-2033)
5.2.3 Global Feline Vaccines Revenue Market Share by Application (2018-2033)
5.3 Global Feline Vaccines Price by Application
5.3.1 Global Feline Vaccines Price by Application (2018-2023)
5.3.2 Global Feline Vaccines Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada Feline Vaccines Market Size by Type
6.1.1 US & Canada Feline Vaccines Sales by Type (2018-2033)
6.1.2 US & Canada Feline Vaccines Revenue by Type (2018-2033)
6.2 US & Canada Feline Vaccines Market Size by Application
6.2.1 US & Canada Feline Vaccines Sales by Application (2018-2033)
6.2.2 US & Canada Feline Vaccines Revenue by Application (2018-2033)
6.3 US & Canada Feline Vaccines Market Size by Country
6.3.1 US & Canada Feline Vaccines Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada Feline Vaccines Sales by Country (2018-2033)
6.3.3 US & Canada Feline Vaccines Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Feline Vaccines Market Size by Type
7.1.1 Europe Feline Vaccines Sales by Type (2018-2033)
7.1.2 Europe Feline Vaccines Revenue by Type (2018-2033)
7.2 Europe Feline Vaccines Market Size by Application
7.2.1 Europe Feline Vaccines Sales by Application (2018-2033)
7.2.2 Europe Feline Vaccines Revenue by Application (2018-2033)
7.3 Europe Feline Vaccines Market Size by Country
7.3.1 Europe Feline Vaccines Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe Feline Vaccines Sales by Country (2018-2033)
7.3.3 Europe Feline Vaccines Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Feline Vaccines Market Size
8.1.1 China Feline Vaccines Sales (2018-2033)
8.1.2 China Feline Vaccines Revenue (2018-2033)
8.2 China Feline Vaccines Market Size by Application
8.2.1 China Feline Vaccines Sales by Application (2018-2033)
8.2.2 China Feline Vaccines Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Feline Vaccines Market Size by Type
9.1.1 Asia Feline Vaccines Sales by Type (2018-2033)
9.1.2 Asia Feline Vaccines Revenue by Type (2018-2033)
9.2 Asia Feline Vaccines Market Size by Application
9.2.1 Asia Feline Vaccines Sales by Application (2018-2033)
9.2.2 Asia Feline Vaccines Revenue by Application (2018-2033)
9.3 Asia Feline Vaccines Sales by Region
9.3.1 Asia Feline Vaccines Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia Feline Vaccines Revenue by Region (2018-2033)
9.3.3 Asia Feline Vaccines Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Feline Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Feline Vaccines Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America Feline Vaccines Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America Feline Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Feline Vaccines Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America Feline Vaccines Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America Feline Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Feline Vaccines Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America Feline Vaccines Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America Feline Vaccines Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck & Co
11.1.1 Merck & Co Company Information
11.1.2 Merck & Co Overview
11.1.3 Merck & Co Feline Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck & Co Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co Recent Developments
11.2 Boehringer Ingelheim International
11.2.1 Boehringer Ingelheim International Company Information
11.2.2 Boehringer Ingelheim International Overview
11.2.3 Boehringer Ingelheim International Feline Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Boehringer Ingelheim International Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim International Recent Developments
11.3 Zoetis (Pfizer)
11.3.1 Zoetis (Pfizer) Company Information
11.3.2 Zoetis (Pfizer) Overview
11.3.3 Zoetis (Pfizer) Feline Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Zoetis (Pfizer) Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis (Pfizer) Recent Developments
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Information
11.4.2 Elanco Animal Health Overview
11.4.3 Elanco Animal Health Feline Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Elanco Animal Health Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Elanco Animal Health Recent Developments
11.5 Virbac
11.5.1 Virbac Company Information
11.5.2 Virbac Overview
11.5.3 Virbac Feline Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Virbac Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Kyoto Biken Laboratories
11.6.1 Kyoto Biken Laboratories Company Information
11.6.2 Kyoto Biken Laboratories Overview
11.6.3 Kyoto Biken Laboratories Feline Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Kyoto Biken Laboratories Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kyoto Biken Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Feline Vaccines Industry Chain Analysis
12.2 Feline Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Feline Vaccines Production Mode & Process
12.4 Feline Vaccines Sales and Marketing
12.4.1 Feline Vaccines Sales Channels
12.4.2 Feline Vaccines Distributors
12.5 Feline Vaccines Customers
13 Market Dynamics
13.1 Feline Vaccines Industry Trends
13.2 Feline Vaccines Market Drivers
13.3 Feline Vaccines Market Challenges
13.4 Feline Vaccines Market Restraints
14 Key Findings in The Global Feline Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Feline Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of F3 (FVRCP) Vaccination
Table 3. Major Manufacturers of Feline Leukaemia Vaccination
Table 4. Major Manufacturers of Rabies Vaccination
Table 5. Major Manufacturers of Heartworm Vaccination
Table 6. Major Manufacturers of Others
Table 7. Global Feline Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Feline Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. Global Feline Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Feline Vaccines Revenue by Region (2024-2033) & (US$ Million)
Table 11. Global Feline Vaccines Revenue Market Share by Region (2018-2023)
Table 12. Global Feline Vaccines Revenue Market Share by Region (2024-2033)
Table 13. Global Feline Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 14. Global Feline Vaccines Sales by Region (2018-2023) & (K Units)
Table 15. Global Feline Vaccines Sales by Region (2024-2033) & (K Units)
Table 16. Global Feline Vaccines Sales Market Share by Region (2018-2023)
Table 17. Global Feline Vaccines Sales Market Share by Region (2024-2033)
Table 18. Global Feline Vaccines Sales by Manufacturers (2018-2023) & (K Units)
Table 19. Global Feline Vaccines Sales Share by Manufacturers (2018-2023)
Table 20. Global Feline Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Feline Vaccines Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Feline Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Feline Vaccines Price by Manufacturers 2018-2023 (US$/Unit)
Table 24. Global Feline Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Feline Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Feline Vaccines as of 2022)
Table 26. Global Key Manufacturers of Feline Vaccines, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Feline Vaccines, Product Offered and Application
Table 28. Global Key Manufacturers of Feline Vaccines, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Feline Vaccines Sales by Type (2018-2023) & (K Units)
Table 31. Global Feline Vaccines Sales by Type (2024-2033) & (K Units)
Table 32. Global Feline Vaccines Sales Share by Type (2018-2023)
Table 33. Global Feline Vaccines Sales Share by Type (2024-2033)
Table 34. Global Feline Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Feline Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 36. Global Feline Vaccines Revenue Share by Type (2018-2023)
Table 37. Global Feline Vaccines Revenue Share by Type (2024-2033)
Table 38. Feline Vaccines Price by Type (2018-2023) & (US$/Unit)
Table 39. Global Feline Vaccines Price Forecast by Type (2024-2033) & (US$/Unit)
Table 40. Global Feline Vaccines Sales by Application (2018-2023) & (K Units)
Table 41. Global Feline Vaccines Sales by Application (2024-2033) & (K Units)
Table 42. Global Feline Vaccines Sales Share by Application (2018-2023)
Table 43. Global Feline Vaccines Sales Share by Application (2024-2033)
Table 44. Global Feline Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Feline Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 46. Global Feline Vaccines Revenue Share by Application (2018-2023)
Table 47. Global Feline Vaccines Revenue Share by Application (2024-2033)
Table 48. Feline Vaccines Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Feline Vaccines Price Forecast by Application (2024-2033) & (US$/Unit)
Table 50. US & Canada Feline Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. US & Canada Feline Vaccines Sales by Type (2024-2033) & (K Units)
Table 52. US & Canada Feline Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Feline Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 54. US & Canada Feline Vaccines Sales by Application (2018-2023) & (K Units)
Table 55. US & Canada Feline Vaccines Sales by Application (2024-2033) & (K Units)
Table 56. US & Canada Feline Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Feline Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 58. US & Canada Feline Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 59. US & Canada Feline Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Feline Vaccines Revenue by Country (2024-2033) & (US$ Million)
Table 61. US & Canada Feline Vaccines Sales by Country (2018-2023) & (K Units)
Table 62. US & Canada Feline Vaccines Sales by Country (2024-2033) & (K Units)
Table 63. Europe Feline Vaccines Sales by Type (2018-2023) & (K Units)
Table 64. Europe Feline Vaccines Sales by Type (2024-2033) & (K Units)
Table 65. Europe Feline Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Feline Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 67. Europe Feline Vaccines Sales by Application (2018-2023) & (K Units)
Table 68. Europe Feline Vaccines Sales by Application (2024-2033) & (K Units)
Table 69. Europe Feline Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Feline Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 71. Europe Feline Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 72. Europe Feline Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Feline Vaccines Revenue by Country (2024-2033) & (US$ Million)
Table 74. Europe Feline Vaccines Sales by Country (2018-2023) & (K Units)
Table 75. Europe Feline Vaccines Sales by Country (2024-2033) & (K Units)
Table 76. China Feline Vaccines Sales by Type (2018-2023) & (K Units)
Table 77. China Feline Vaccines Sales by Type (2024-2033) & (K Units)
Table 78. China Feline Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Feline Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 80. China Feline Vaccines Sales by Application (2018-2023) & (K Units)
Table 81. China Feline Vaccines Sales by Application (2024-2033) & (K Units)
Table 82. China Feline Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Feline Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 84. Asia Feline Vaccines Sales by Type (2018-2023) & (K Units)
Table 85. Asia Feline Vaccines Sales by Type (2024-2033) & (K Units)
Table 86. Asia Feline Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Feline Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 88. Asia Feline Vaccines Sales by Application (2018-2023) & (K Units)
Table 89. Asia Feline Vaccines Sales by Application (2024-2033) & (K Units)
Table 90. Asia Feline Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Feline Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 92. Asia Feline Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 93. Asia Feline Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Feline Vaccines Revenue by Region (2024-2033) & (US$ Million)
Table 95. Asia Feline Vaccines Sales by Region (2018-2023) & (K Units)
Table 96. Asia Feline Vaccines Sales by Region (2024-2033) & (K Units)
Table 97. Middle East, Africa and Latin America Feline Vaccines Sales by Type (2018-2023) & (K Units)
Table 98. Middle East, Africa and Latin America Feline Vaccines Sales by Type (2024-2033) & (K Units)
Table 99. Middle East, Africa and Latin America Feline Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Feline Vaccines Revenue by Type (2024-2033) & (US$ Million)
Table 101. Middle East, Africa and Latin America Feline Vaccines Sales by Application (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Feline Vaccines Sales by Application (2024-2033) & (K Units)
Table 103. Middle East, Africa and Latin America Feline Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Feline Vaccines Revenue by Application (2024-2033) & (US$ Million)
Table 105. Middle East, Africa and Latin America Feline Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 106. Middle East, Africa and Latin America Feline Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Feline Vaccines Revenue by Country (2024-2033) & (US$ Million)
Table 108. Middle East, Africa and Latin America Feline Vaccines Sales by Country (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Feline Vaccines Sales by Country (2024-2033) & (K Units)
Table 110. Merck & Co Company Information
Table 111. Merck & Co Description and Major Businesses
Table 112. Merck & Co Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Merck & Co Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck & Co Recent Developments
Table 115. Boehringer Ingelheim International Company Information
Table 116. Boehringer Ingelheim International Description and Major Businesses
Table 117. Boehringer Ingelheim International Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Boehringer Ingelheim International Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim International Recent Developments
Table 120. Zoetis (Pfizer) Company Information
Table 121. Zoetis (Pfizer) Description and Major Businesses
Table 122. Zoetis (Pfizer) Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Zoetis (Pfizer) Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Zoetis (Pfizer) Recent Developments
Table 125. Elanco Animal Health Company Information
Table 126. Elanco Animal Health Description and Major Businesses
Table 127. Elanco Animal Health Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Elanco Animal Health Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Elanco Animal Health Recent Developments
Table 130. Virbac Company Information
Table 131. Virbac Description and Major Businesses
Table 132. Virbac Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Virbac Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Virbac Recent Developments
Table 135. Kyoto Biken Laboratories Company Information
Table 136. Kyoto Biken Laboratories Description and Major Businesses
Table 137. Kyoto Biken Laboratories Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Kyoto Biken Laboratories Feline Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Kyoto Biken Laboratories Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Feline Vaccines Distributors List
Table 143. Feline Vaccines Customers List
Table 144. Feline Vaccines Market Trends
Table 145. Feline Vaccines Market Drivers
Table 146. Feline Vaccines Market Challenges
Table 147. Feline Vaccines Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Feline Vaccines Product Picture
Figure 2. Global Feline Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Feline Vaccines Market Share by Type in 2022 & 2033
Figure 4. F3 (FVRCP) Vaccination Product Picture
Figure 5. Feline Leukaemia Vaccination Product Picture
Figure 6. Rabies Vaccination Product Picture
Figure 7. Heartworm Vaccination Product Picture
Figure 8. Others Product Picture
Figure 9. Global Feline Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 10. Global Feline Vaccines Market Share by Application in 2022 & 2033
Figure 11. Prevention of Feline Panleukopaenia
Figure 12. Prevention of Feline Rhinotracheitis
Figure 13. Prevention of Feline Calicivirus
Figure 14. Others
Figure 15. Feline Vaccines Report Years Considered
Figure 16. Global Feline Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Feline Vaccines Revenue 2018-2033 (US$ Million)
Figure 18. Global Feline Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 19. Global Feline Vaccines Revenue Market Share by Region (2018-2033)
Figure 20. Global Feline Vaccines Sales 2018-2033 ((K Units)
Figure 21. Global Feline Vaccines Sales Market Share by Region (2018-2033)
Figure 22. US & Canada Feline Vaccines Sales YoY (2018-2033) & (K Units)
Figure 23. US & Canada Feline Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 24. Europe Feline Vaccines Sales YoY (2018-2033) & (K Units)
Figure 25. Europe Feline Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 26. China Feline Vaccines Sales YoY (2018-2033) & (K Units)
Figure 27. China Feline Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 28. Asia (excluding China) Feline Vaccines Sales YoY (2018-2033) & (K Units)
Figure 29. Asia (excluding China) Feline Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Feline Vaccines Sales YoY (2018-2033) & (K Units)
Figure 31. Middle East, Africa and Latin America Feline Vaccines Revenue YoY (2018-2033) & (US$ Million)
Figure 32. The Feline Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Feline Vaccines in the World: Market Share by Feline Vaccines Revenue in 2022
Figure 34. Global Feline Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Feline Vaccines Sales Market Share by Type (2018-2033)
Figure 36. Global Feline Vaccines Revenue Market Share by Type (2018-2033)
Figure 37. Global Feline Vaccines Sales Market Share by Application (2018-2033)
Figure 38. Global Feline Vaccines Revenue Market Share by Application (2018-2033)
Figure 39. US & Canada Feline Vaccines Sales Market Share by Type (2018-2033)
Figure 40. US & Canada Feline Vaccines Revenue Market Share by Type (2018-2033)
Figure 41. US & Canada Feline Vaccines Sales Market Share by Application (2018-2033)
Figure 42. US & Canada Feline Vaccines Revenue Market Share by Application (2018-2033)
Figure 43. US & Canada Feline Vaccines Revenue Share by Country (2018-2033)
Figure 44. US & Canada Feline Vaccines Sales Share by Country (2018-2033)
Figure 45. U.S. Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 46. Canada Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 47. Europe Feline Vaccines Sales Market Share by Type (2018-2033)
Figure 48. Europe Feline Vaccines Revenue Market Share by Type (2018-2033)
Figure 49. Europe Feline Vaccines Sales Market Share by Application (2018-2033)
Figure 50. Europe Feline Vaccines Revenue Market Share by Application (2018-2033)
Figure 51. Europe Feline Vaccines Revenue Share by Country (2018-2033)
Figure 52. Europe Feline Vaccines Sales Share by Country (2018-2033)
Figure 53. Germany Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 54. France Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 55. U.K. Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 56. Italy Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 57. Russia Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 58. China Feline Vaccines Sales Market Share by Type (2018-2033)
Figure 59. China Feline Vaccines Revenue Market Share by Type (2018-2033)
Figure 60. China Feline Vaccines Sales Market Share by Application (2018-2033)
Figure 61. China Feline Vaccines Revenue Market Share by Application (2018-2033)
Figure 62. Asia Feline Vaccines Sales Market Share by Type (2018-2033)
Figure 63. Asia Feline Vaccines Revenue Market Share by Type (2018-2033)
Figure 64. Asia Feline Vaccines Sales Market Share by Application (2018-2033)
Figure 65. Asia Feline Vaccines Revenue Market Share by Application (2018-2033)
Figure 66. Asia Feline Vaccines Revenue Share by Region (2018-2033)
Figure 67. Asia Feline Vaccines Sales Share by Region (2018-2033)
Figure 68. Japan Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 69. South Korea Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 70. China Taiwan Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 71. Southeast Asia Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 72. India Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Feline Vaccines Sales Market Share by Type (2018-2033)
Figure 74. Middle East, Africa and Latin America Feline Vaccines Revenue Market Share by Type (2018-2033)
Figure 75. Middle East, Africa and Latin America Feline Vaccines Sales Market Share by Application (2018-2033)
Figure 76. Middle East, Africa and Latin America Feline Vaccines Revenue Market Share by Application (2018-2033)
Figure 77. Middle East, Africa and Latin America Feline Vaccines Revenue Share by Country (2018-2033)
Figure 78. Middle East, Africa and Latin America Feline Vaccines Sales Share by Country (2018-2033)
Figure 79. Brazil Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 80. Mexico Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 81. Turkey Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 82. Israel Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 83. GCC Countries Feline Vaccines Revenue (2018-2033) & (US$ Million)
Figure 84. Feline Vaccines Value Chain
Figure 85. Feline Vaccines Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed